VEA
DTIL icon

Virtus ETF Advisers’s Precision BioSciences DTIL Stock Holding History

Virtus ETF Advisers’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-632
Closed -$58K – 453
2022
Q1 		$58K Sell
632
-37
-6% -$5.03K 0.03% 361
2021
Q4 		$149K Buy
669
+59
+10% +$16.5K 0.06% 351
2021
Q3 		$211K Sell
610
-32
-5% -$10.8K 0.09% 259
2021
Q2 		$241K Sell
642
-604
-48% -$181K 0.1% 221
2021
Q1 		$387K Buy
1,246
+21
+2% +$7.35K 0.16% 189
2020
Q4 		$306K Sell
1,225
-148
-11% -$36.3K 0.13% 203
2020
Q3 		$254K Sell
1,373
-188
-12% -$37.4K 0.13% 259
2020
Q2 		$390K Buy
1,561
+396
+34% +$86.7K 0.18% 208
2020
Q1 		$211K Sell
1,165
-170
-13% -$44.5K 0.09% 274
2019
Q4 		$556K Buy
+1,335
New +$419K 0.09% 197

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Virtus ETF Advisers's DTIL Position: Q2 2022 in Review

Virtus ETF Advisers sold out of Precision BioSciences (DTIL) in Q2 2022, closing a stake of 632 shares — an estimated $58K sold.

Virtus ETF Advisers first reported a position in DTIL in Q4 2019 and held it in 10 quarters. The position peaked at $556K in Q4 2019. 119 funds tracked by Wall St. Rank hold DTIL as of Q2 2022.

  • Virtus ETF Advisers reported no remaining Precision BioSciences position as of Q2 2022 after selling out during the quarter.
  • Virtus ETF Advisers sold 632 Precision BioSciences shares in Q2 2022, an estimated $58K.
  • Virtus ETF Advisers first reported a position in Precision BioSciences in Q4 2019 and held it in 10 quarters.
  • Virtus ETF Advisers's Precision BioSciences position peaked at $556K in Q4 2019.
  • 119 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2022.

Based on Virtus ETF Advisers's 13F filing for Q2 2022, filed 12 Aug 2022.